Alnylam Pharmaceuticals
ALNY
ALNY
495 hedge funds and large institutions have $17.2B invested in Alnylam Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 203 increasing their positions, 150 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
495
Holders Change
+1
Holders Change %
+0.2%
% of All Funds
7.17%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.12%
New
71
Increased
203
Reduced
150
Closed
63
Calls
$461M
Puts
$304M
Net Calls
+$157M
Net Calls Change
+$211M
Top Buyers
| 1 |
American Century Companies
Kansas City,
Missouri
|
+$143M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$124M |
| 3 |
BlackRock
New York
|
+$75.3M |
| 4 |
VPC
Vestal Point Capital
New York
|
+$47.1M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$43M |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$506M |
| 2 |
RI
RTW Investments
New York
|
-$314M |
| 3 |
JPMorgan Chase & Co
New York
|
-$189M |
| 4 |
Morgan Stanley
New York
|
-$140M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$121M |
